Plasma EGF levels predict cognitive decline in Parkinson's Disease

OBJECTIVE: Most people with Parkinson's disease (PD) eventually develop cognitive impairment (CI). However, neither the timing of onset nor the severity of cognitive symptoms can be accurately predicted. We sought plasma-based biomarkers for CI in PD. METHODS: A discovery cohort of 70 PD patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chen-Plotkin, Alice S., Hu, William T., Siderowf, Andrew, Weintraub, Daniel, Gross, Rachel Goldmann, Hurtig, Howard I., Xie, Sharon X., Arnold, Steven E., Grossman, Murray, Clark, Christopher M., Shaw, Leslie M., McCluskey, Leo, Elman, Lauren, Van Deerlin, Vivianna M., Lee, Virginia M.-Y., Soares, Holly, Trojanowski, John Q.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3155276/
https://ncbi.nlm.nih.gov/pubmed/21520231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.22271
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados